Tandem Diabetes Care (TNDM) Shares Outstanding (2013 - 2026)

Tandem Diabetes Care (TNDM) has 14 years of Shares Outstanding (Entity) data on file, last reported at $68.5 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 2.91% year-over-year to $68.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $68.5 million (up 2.91% YoY) and the FY2025 annual result came in at $68.3 million, up 3.06% from the prior year.
• Shares Outstanding (Entity) was little changed at $68.5 million in Q1 2026, from $68.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $68.5 million in Q1 2026 to a low of $63.9 million in Q1 2022.
• A 5-year average of $65.8 million and a median of $65.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) retreated 0.07% — and 2025, when it gained 3.24%.
• Tracing TNDM's Shares Outstanding (Entity) over 5 years: stood at $64.5 million in 2022, then gained by 1.61% to $65.6 million in 2023, then increased by 1.09% to $66.3 million in 2024, then gained by 3.06% to $68.3 million in 2025, then rose by 0.31% to $68.5 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $68.5 million (Q1 2026), $68.3 million (Q4 2025), and $67.8 million (Q3 2025), per Business Quant data.